Skip to content
During a busy week in Congress, House legislation to support drug development for pediatric rare diseases moved forward with bipartisan support, and a Senate […]
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA Read More »
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
John Torres, Senior Director, Federal Government Relations – Agriculture and Environment at the Biotechnology Innovation Organization (BIO), was recently appointed to the U.S. Department
BIO’s John Torres on his appointment to the ATAC and the future of agricultural trade Read More »
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric
Four key facts ahead of tomorrow’s drug pricing hearing Read More »
Members of Congress discussed legislation to block proposed federal rules that would regulate growth of genetically engineered crops on wildlife refuges during a Sept.
House members seek to block new wildlife refuge rules regarding GE crops Read More »
Market concentration allows pharmacy benefit managers (PBMs) to siphon off funds from our health care system while increasing costs to patients and reducing access
House hearing delves into antitrust problems of PBMs Read More »
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the
New survey checks pulse on voters’ concerns for innovation and biomanufacturing Read More »
“The world of biotechnology is in the midst of a wave of exciting research and clinical advances—from artificial intelligence-based drug discovery to cell and
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward Read More »
In the season opener of the I am BIO Podcast, Dr. David Fajgenbaum shares his journey from patient to scientist, explaining how his battle
I am BIO Podcast: How Dr. David Fajgenbaum saved his own life Read More »
